Correction: Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456546/
https://www.ncbi.nlm.nih.gov/pubmed/32816781
http://dx.doi.org/10.1136/annrheumdis-2019-216274corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456546/
https://www.ncbi.nlm.nih.gov/pubmed/32816781
http://dx.doi.org/10.1136/annrheumdis-2019-216274corr1

Ejemplares similares